Relationship of Hepatitis B or C Virus Prevalences, Risk Factors, and Outcomes in Renal Transplant Recipients: Analysis of German Data

Transplantation Proceedings

Volumn 40, Issue 4, 2008, Pages 909-914

  Kliem, V ^a,b   Burg, M ^a   Haller, H ^b   Suwelack, B ^b   Abendroth, D ^b   Fritsche, L ^b   Fornara, P ^b   Pietruck, F ^b   Frei, U ^b   Donauer, J ^b   Lison, A E ^b   Michel, U ^b  

^a Nephrological Center   (Germany)

^b Novartis Pharma ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GERMANY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETRANSPLANTATION; RISK FACTOR; SEROLOGY;

ADULT; BLOOD TRANSFUSION; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 44949249751     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.031     Document Type: Article

References (42)

1. Morales J.M., and Campistol J.M. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 11 (2000) 1343
2. Green M., Avery R.K., and Preiksaitis J. Viral hepatitis guidelines in hemodialysis and transplantation. Am J Transplant 4 suppl 10 (2004) 72
3. Pedroso S., Martins L., Fonseca I., et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc 38 (2006) 1890
4. Kliem V., Ringe B., Holhorst K., et al. Kidney transplantation in hepatitis B surface antigen carriers. Clin Invest 72 (1994) 1000
5. Kliem V., van den Hoff U., Brunkhorst R., et al. The long-term course of hepatitis C after kidney transplantation. Transplantation 62 (1996) 1417
6. Kamar N., Rostaing L., Selves J., et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 5 (2005) 1701
7. Chan T.M., Lok A.S.F., and Cheng I.K.P. Hepatitis C in renal transplant recipients. Transplantation 52 (1991) 810
8. Breitenfeldt M.K., Rasenack J., Berthold H., et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transpl 16 (2002) 130
9. Lin H.-H., Huang C.-C., Huang J.-Y., et al. Impact of HCV infection on first cadaveric renal transplantation, a single center experience. Clin Transpl 18 (2004) 261
10. Morales J.M., Dominguez-Gil B., Sanz-Guajardo D., et al. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant 19 suppl 3 (2004) iii72
11. Bruchfeld A., Wilczek H., and Elinder C.G. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation 78 (2004) 745
12. Aroldi A., Lampertico P., Montagnino G., et al. Natural history of hepatitis C virus infection in adult renal graft recipients. Transplant Proc 37 (2005) 940
13. Narula A.S., Hooda A., Anand A.C., et al. Impact of hepatitis C virus infection in renal transplant recipients. Indian J Gastroenterol 24 (2005) 151
14. Unal E., Turkmen F., Sevinc C., et al. Outcome of renal allograft in Turkish patients with pretransplantation hepatitis C virus infection. Transplant Proc 38 (2006) 3448
15. Mitwalli A.H., Alam A., Al-Wakeel J., et al. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract 102 (2006) c72
16. Behzad-Behbahani A., Mojiri A., Tabei S.Z., et al. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc 37 (2005) 3045
17. Chan T.M., Chapman J., Lee C.J., et al. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries. Transplant Proc 36 (2004) 2126
18. Fabrizi F., Martin P., Dixit V., et al. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5 (2005) 2913
19. Salvadori M., Rosati A., Bock A., et al. One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST observational study. Transplant Proc 35 (2003) 2863
20. Salvadori M., Rosati A., Bertoni E., et al. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study. Transplant Proc 38 (2006) 1010
21. Kliem V., Fritsche L., Haller H., et al. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the multinational observational study (MOST). Transplant Proc 37 (2005) 1597
22. Dienstag J.L. Non-A, non-B hepatitis: I. Recognition, epidemiology and clinical features. Gastroenterology 85 (1983) 439
23. Alter H.J., Purcell R.H., Shih J.W., et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321 (1989) 1494
24. Estebàn J.I., Gonzáles A., Hernández J.M., et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 23 (1990) 1107
25. Correa J.R., Rocha F., Peres A.A., et al. Long-term impact of hepatitis B and C virus infection in kidney transplant recipient's survival. Transplant Proc 35 (2003) 1076
26. Einollahi B., Hajarizadeh B., Bakhtiari S., et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 18 (2003) 836
27. Kliem V, Michel U, Burg M, et al: Geographical prevalences, risk factors and impacts of hepatitis B and C after renal transplantation: subgroup analysis within the Multinational Observational Study in Transplantation (MOST). Transplant Proc (in press)
28. Meier-Kriesche H.U., Ojo A.O., Hanson J.A., et al. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 72 (2001) 241
29. Huang C.C., Lai M.K., and Fong M.T. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. Transplantation 49 (1990) 540
30. Rao K.V., Kasiske B.L., and Anderson W.R. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 51 (1991) 391
31. Roth D., Zucker K., Cirocco R., et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45 (1994) 238
32. Mathurin P., Mouquet C., Poynard T., et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29 (1999) 257
33. Sabet S., Hakemi M., Nadjafi I., et al. Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study. Transplant Proc 35 (2003) 2699
34. Manga Sahin G., Sahin S., Kantarci G., et al. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation. Transplant Proc 38 (2006) 499
35. Mahmoud I.M., Elhabashi A.F., Elsawy E., et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 43 (2004) 131
36. Glicklich D., Thung S.W., Kapoian T., et al. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant patients. Am J Gastroenterol 94 (1999) 159
37. Matos C.A.L., Perez R.M., Lemos L.B., et al. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection. Eur J Gastroenterol Hepatol 19 (2007) 653
38. Goffin E., Pirson Y., Cornu C., et al. Outcome of HCV infection after renal transplantation. Kidney Int 45 (1994) 551
39. Hanafusa T., Ichikawa Y., Kishikawa H., et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 66 (1998) 471
40. Nakagawa M., Sakamoto N., Enomoto N., et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 313 (2004) 42
41. Fabrizi F., Bromberg J., Elli A., et al. Hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther 22 (2005) 657
42. Watashi K., and Shimotohno K. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy. Rev Med Virol 17 (2007) 245